메뉴 건너뛰기




Volumn 90, Issue 4, 2010, Pages 433-434

Skin necrosis revealing antiphospholipid syndrome during immunotherapy for melanoma

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; CALCIUM CHANNEL STIMULATING AGENT; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN G; RHEUMATOID FACTOR; THYROGLOBULIN ANTIBODY; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; MACROGOL DERIVATIVE; PEGINTERFERON ALPHA2B; RECOMBINANT PROTEIN;

EID: 77954926623     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0877     Document Type: Letter
Times cited : (7)

References (5)
  • 2
    • 33344458573 scopus 로고    scopus 로고
    • International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
    • Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
    • (2006) J Thromb Haemost , vol.4 , pp. 295-306
    • Miyakis, S.1    Lockshin, M.D.2    Atsumi, T.3    Branch, D.W.4    Brey, R.L.5    Cervera, R.6
  • 3
    • 0028205754 scopus 로고
    • Anti-phospholipid syndrome associated with immunotherapy for patients with melanoma
    • Becker JC, Winkler B, Klingert S, Brocker EB. Anti-phospholipid syndrome associated with immunotherapy for patients with melanoma. Cancer 1994; 73: 1621-1624.
    • (1994) Cancer , vol.73 , pp. 1621-1624
    • Becker, J.C.1    Winkler, B.2    Klingert, S.3    Brocker, E.B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.